These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8351722)

  • 21. Peripheral blood chemiluminescence as an early indicator of successful bone marrow transplantation.
    Toivanen A; Nikoskelainen J; Lilius EM; Salmi TT; Kätkä K; Pelliniemi TT; Mäki AL; Rajamäki A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2745-6. PubMed ID: 3079095
    [No Abstract]   [Full Text] [Related]  

  • 22. Current status of bone marrow transplantation for severe aplastic anemia: a preliminary report from the International Bone Marrow Transplant Registry.
    Gluckman E
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2597-9. PubMed ID: 3547940
    [No Abstract]   [Full Text] [Related]  

  • 23. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation for severe aplastic anemia.
    Speck B
    Semin Hematol; 1991 Oct; 28(4):319-21. PubMed ID: 1759173
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
    Lanino E; Lamparelli T; Dini G; Alessandrino EP; Aversa F; Calori E; Medugno D; Garbarino L; Locatelli F; Marenco P
    Bone Marrow Transplant; 1993; 11 Suppl 1():88-9. PubMed ID: 8448560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allogeneic bone marrow transplantation for aplastic anemia].
    Ohashi H
    Nihon Rinsho; 1990 Sep; 48(9):2096-101. PubMed ID: 2232216
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone marrow transplantation in children].
    Poros A
    Orv Hetil; 1993 Jun; 134(25):1387. PubMed ID: 8332358
    [No Abstract]   [Full Text] [Related]  

  • 30. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unrelated bone marrow transplantation in two severe aplastic anemia patients preconditioned with a regimen of cyclophosphamide, antithymocyte globulin, and total body irradiation].
    Mizue N; Watanabe J; Katoh S; Oda T; Suzuki N; Kudoh T
    Rinsho Ketsueki; 1999 Mar; 40(3):213-7. PubMed ID: 10222628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia.
    Rodriguez V; Khan SP
    Transplant Proc; 2002 Jun; 34(4):1307-9. PubMed ID: 12072347
    [No Abstract]   [Full Text] [Related]  

  • 33. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone marrow transplantation in the treatment of aplastic anemia patients].
    Fedorovskaia NA; Svedentsov EP; Sharygin SL; Epifanov NS
    Ter Arkh; 1993; 65(3):92-5. PubMed ID: 8059398
    [No Abstract]   [Full Text] [Related]  

  • 37. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia.
    Dezern AE; Luznik L; Fuchs EJ; Jones RJ; Brodsky RA
    Bone Marrow Transplant; 2011 Jul; 46(7):1012-3. PubMed ID: 20838390
    [No Abstract]   [Full Text] [Related]  

  • 39. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance.
    Stachel D; Schmid I; Lang T; Haas RJ; Otté JB
    Transpl Int; 2002 Jan; 15(1):39-44. PubMed ID: 11875612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes virus immunity and acute graft-versus-host disease.
    Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.